Introduction. We applied pressure stress to human aortic endothelial cells (HAEC) and investigated whether mechanical pressure stress and/or angiotensin II (Ang II) affected angiotensin-converting enzyme (ACE) 2. We then tested whether the administration of nifedipine had a demonstrable and possibly beneficial effect. Methods. A pulsatile atmospheric pressure with or without Ang II was loaded on HAECs. The expression of ACE2 was studied by immunoblots and reverse transcription/real-time polymerase chain reaction. Results. The pulsatile mechanical pressure increased the expression of ACE2 mRNA by approximately 80%. Supplementation of Ang II (1 mM) with pulsatile mechanical pressure decreased the expression of ACE2 mRNA by approximately 54%. Pulsatile atmospheric pressure increased ACE2 protein, but supplementation of Ang II (1 mM) also increased ACE2 protein, and the latter failed to show significant change compared to pressurized control without Ang II. Ang II administration reduced ACE2 protein in the membranous fraction under pressurized condition. Administration of nifedipine (1 mM) protected cells from this ACE2 protein reduction at the HAEC membrane.
Introduction
Regulation of the renin-angiotensin system is a well-established strategy that has been used for the treatment of cardiovascular diseases during the past few decades. Two types of angiotensinconverting enzyme (ACE) have been noted, and the clinical importance of conventional ACE (i.e. not only the validity of its blood pressureregulating effect by the production of angiotensin II (Ang II), but also the benefits beyond blood pressure lowering provided by agents that inhibit ACE activity) has been reported. 1, 2 ACE2 is another type of ACE, and the findings of this molecule as an Ang II breakdown enzyme indicate that a new therapeutic strategy for blood pressure regulation may be developed. 3 The recent studies of ACEs indicated the mechanisms for the regulation of gene expression, 4 localization, 5 and the presence of homologues 6 as well as multiple transcripts. 7 However, the physiological and pathological functions of local ACE2, especially in human endothelial cells, and the effect of Ang II and/or pressure stress have not been well characterized.
Recently, we reported that a particular type of mechanical stress, a pulsatile atmospheric pressure produced by an original pure pressureloading apparatus, has a cell proliferating effect and modulates the activities of cell-surface ACE in human aortic smooth muscle cells. 8 In the present study, we used this device to show the effect on the expression of ACE2 and the localization of ACE2 in human aortic endothelial cells (HAEC) when cells were exposed to pulsatile-mechanical pressure stress in the presence or absence of Ang II. In so doing, we tested the hypothesis of possible beneficial actions of a calcium channel blocker in an experimental setting.
Paper SAGE Publications 2009 Los Angeles, London, New Delhi and Singapore serum, gentamicin (50 mg/ml), amphotericin (50 mg/ml), and the following growth factors: human epidermal growth factor (10 ng/ml), human fibroblast growth factor (5.0 ng/ml), heparin (10 mg/ml) and hydrocortisone (1.0 mg/ml). HAECs were incubated at 37°C in a humidified atmosphere containing 5% CO 2 . The second passage of HAECs was divided into several batches and stored in a -150°C freezer. The sixth through to eighth passages of HAECs from a single batch were utilised for further investigations. Different repetitions of the experiments were performed with different passage-number HAECs.
Pulsatile pressure-loading apparatus
An originally designed pulsatile pressure-loading apparatus was utilized in these experiments, as described previously. 8 In brief, HAECs were cultured on 100-mm dishes, and the medium was changed to a starvation medium (Dulbecco's modified Eagle's medium without serum) at 24 hours before experiments. Cell culture dishes were placed in the pressure-loading apparatus in a starvation medium, and then HAECs were exposed to pulsatile atmospheric pressure (between 80 and 160 mmHg) for 24 hours at a rate of 11 cycles/min. Ang II (Sigma, USA) (1 mM) and/or nifedipine (Sigma) (1 mM) were supplemented with culture medium at the beginning of pressurization. An Ang II concentration of 1 mM was utilized throughout the experiments based on the results described previously. 8 Nonpressurized control HAECs were placed in a 5% CO 2 incubator at 37°C with or without Ang II.
Immunoblotting
Crude samples from HAECs were prepared by direct homogenisation with protease inhibitor cocktails according to a procedure described previously. 9 Fractionated samples from HAECs were prepared using a subcellular proteome extraction kit (Calbiochem, USA), according to the manufacturer's instructions. Fractions I and II thus obtained were analyzed by immunoblots for the detection of ACE2 protein with anti-ACE2 antibody (R&D Systems Inc., USA) and the amounts in the cytosolic fraction and membranous fraction were determined, respectively. The protein concentration of each sample was set at 5 mg using a modified Lowry's method by BCA protein assay kit (Pierce, USA), and digitized data of ACE2 expression were normalised to the amount of b-actin expression, with the results given in relative values (AU) compared to b-actin.
RNA isolation and reverse transcription/realtime polymerase chain reaction (PCR)
Total RNA was extracted using TRI Reagent (Sigma). RNA (2 mg) was reverse transcribed and amplified by PCR (50°C for 3 minutes, 95°C for 5 minutes, 40 cycles, and then 95°C for 15 seconds, 60°C for 50 seconds) followed by 1 minute of final extension with SuperScript III Platinum SYBR Green one-step qRT-PCR kit (Invitrogen) on an ABI7500 Fast Real-Time PCR system. The forward primer for ACE2 was 5'-TCCGTCTGAATGACAACAG-3', and the reverse primer was 5'-ACAATGCCAACCACTATCAC-3'. Similar conditions were used to amplify glyceraldehyde-3-phosphate dehydrogenase (GAPDH) using the forward primer 5'-TCATGGGTGTGAAC CATGAGA-3' and reverse primer 5'-TGATGT CATCATATTTGGCAGG-3'. The results were quantified as Ct values, where Ct was defined as the threshold cycle of PCR at which the amplified product was first detected and expressed as a relative expression (the ratio of target to GAPDH). The mRNA expression of GAPDH used as a housekeeping gene remained stable even under the pressurized conditions (data not shown). The obtained results are given as relative values, i.e. expressed in an arbitrary unit (AU) relative to the values of the non-pressurized vehicle-treated control, which are set at 1.0.
Experimental protocols
Evaluation of the effects of pulsatile pressure and Ang II on ACE2 mRNA Cultured HAECs were treated under pulsatile (80 mmHg through to 160 mmHg) pressure for 24 hours at 37°C. Ang II or vehicle was administered to non-pressurized and to pressurized HAECs. After 24 hours of incubation, mRNA was purified from HAECs and the expression of ACE2 was detected by reverse transcription/real-time PCR. ACE2 expression was normalised to GAPDH expression.
Evaluation of the effects of pulsatile pressure and Ang II on ACE2 protein in a crude and fractionated sample
Cultured HAECs were placed in the pulsatile (80 mmHg through to 160 mmHg) pressure apparatus for 24 hours at 37°C. Ang II or vehicle was administered to non-pressurized and to pressurized HAECs. After 24 hours of incubation, ACE2 protein expression in crude extracts was quantified by immunoblots followed by densitometric analysis. ACE2 protein expression in fractionated cell extracts was analyzed by immunoblots. 
Evaluation of the effects of nifedipine on ACE2 under pressurized conditions supplemented with
Ang II Cultured HAECs were placed in the pulsatile (80 mmHg through to 160 mmHg) pressure apparatus for 24 hours at 37°C. Ang II or nifedipine was administered to pressurized HAECs. After 24 hours of incubation, ACE2 protein expression on fractionated cell extracts was quantified by immunoblots followed by densitometric analysis.
Statistics
Data are expressed as the mean±SD. Significant differences between groups were examined using analysis of variance and the post hoc Bonferroni, Dunn test to investigate inter-and intra-group hypotheses. Statistical significance was set throughout at p<0.05.
Results

Effects of pulsatile pressure and Ang II on ACE2 mRNA
Our first investigation in the present study was the identification of the effect of pure mechanical pressure on ACE2 using a pressurization system that enabled us to simulate the effect of systolic hypertension on HAECs. Supplementation of Ang II decreased the expression of ACE2 mRNA by approximately 43% compared with that of the non-pressurized vehicle. The pulsatile mechanical pressure resulted in an increase in the expression of ACE2 mRNA by approximately 80% compared with that of the non-pressurized vehicle. Supplementation of Ang II (1 mM) with pulsatile mechanical pressure on HAECs resulted in a decrease in the expression of ACE2 mRNA by approximately 54% compared to the pressurized sample without Ang II (figure 1).
Effects of pulsatile pressure and Ang II on ACE2 protein in a crude and fractionated sample
Administration of Ang II (1 mM) in HAECs resulted in an increase in ACE2 protein by approximately 73% under the non-pressurized condition compared to the vehicle control (figure 2). These data indicated the usability from different passages and the availability of Ang II receptors on the HAECs used in these experiments.
Pulsatile atmospheric pressure without Ang II increased ACE2 protein by approximately 136% compared to that of the non-pressurized vehicle control. The supplementation of Ang II (1 mM) with pulsatile atmospheric pressure resulted in an increase in ACE2 protein by approximately 120% compared to the non-pressurized control with Ang II, and failed to show a significant change compared to pressurized control without Ang II.
In fractionated samples, the administration of Ang II (1 mM) resulted in an increase in ACE2 protein in both the membranous and cytosolic fraction under the non-pressurized condition compared to the vehicle control ( figure 3) . Pulsatile atmospheric pressure without Ang II increased ACE2 protein predominantly in the membranous fraction compared to that of the non-pressurized sample with Ang II. The supplementation of Ang II (1 mM) with pulsatile atmospheric pressure resulted in an increase in ACE2 protein predominantly in the cytosolic fraction and in decreased ACE2 protein in the membranous fraction compared to that of the pressurized sample without Ang II.
Effects of nifedipine on ACE2 under pressurized conditions supplemented with Ang II
The supplementation of Ang II (1 mM) with pulsatile atmospheric pressure resulted in an increase in the amount of ACE2 protein in the cytosol by approximately 41% and a decrease in the membranous fraction by approximately 42% compared to a pressurized control, with densitometric analyses performed on the immunoblots shown in figure 3 (figure 4) . The administration of nifedipine (1 mM) with Ang II (1 mM) increased the ACE2 protein amount at the membrane and decreased the ACE2 protein in the cytosol compared to that of the pressurized sample with Ang II.
Discussion
ACE2 is a membrane-bound enzyme responsible for the cleavage of Ang II; it participates in the production of vasodilatory peptides such as angiotensin-(1-7). 10 Recent advances pointed out the role of Mas as a functional target of angiotensin-(1-7) produced by ACE2 or ACE via angiotensin-(1-9), 11 and this so-called 'ACE2angiotensin-(1-7)-Mas axis' 12 has been shown to yield beneficial actions by counteracting Ang II and angiotensin II type 1 receptor-mediated effects. 13 Conversely, overexpression of ACE2 in the heart has been reported to cause several disadvantages, 14 demonstrating the complexity of the renin-angiotensin system.
ACE2 mRNA expression has been shown to localize in atherosclerotic lesions 15 as well as in endothelial cells in humans, 16 where most of the mechanical stresses are acting (one such stress is pressure, and thus pressure was used in this study). ACE2 mRNA expression has been reported to be decreased in most of the cardiovascular diseases, 17, 18 and in an adult hypertensive model, 19 including human renal tissues. 20 However, a study at birth showed ACE2 mRNA to be increased in a hypertensive animal model. 21 The disparity between the results of our study of HAECs and those of other reports may be partly explained by the time during which cells were exposed to the pressure stresses. On the other hand, the administration of Ang II has been known to down-regulate ACE2 mRNA expression in smooth muscle cells 22 and kidney epithelial cells. 23 The results of previous studies with angiotensin II type 1 receptor-selective antagonists 24, 25 suggested that these reductions of ACE2 expression may be related to the stimulation of the angiotensin II type 1 receptor. Our data regarding ACE2 mRNA obtained under non-pressurized and pressurized conditions with HAECs exhibited good correspondence with these previous results.
Supplementation of Ang II under pressurized conditions failed to show a significant change in ACE2 protein expression in crude samples. However, analysis of a fractionated sample demonstrated that, surprisingly, Ang II administration gave rise to a reduction of ACE2 protein in the membranous fraction and increased ACE2 protein in the cytosolic fraction. To our knowledge, there have been no previous reports of this type of localized change in ACE2 in HAECs due to Ang II administration under pressurized conditions in vitro. ACE is a member of a group of transmembrane ectoproteins and is known to be solubilised by proteolytic cleavage. 26 Several types of proteases are known to produce a truncated form of ACE, and secretase 27 and membrane-associated metalloproteinases (MMP) 28 are candidates for the production of a secreted form of ACE into the circulation. Previous reports demonstrated that MMPs are activated by mechanical stress such as stretching, 29 and Ang II 30 also facilitates MMP activity. From these observations, we suggest that cell-surface ACE2 may be catalysed by proteases under the presence of pressurization when supplemented with Ang II in HAECs. Additional experiments may be required to test the timecourse change on ACE2 mRNA and protein, concomitant with the detection of released ACE2 protein in culture medium.
As shown in an earlier clinical trial, 31 the effectiveness of calcium channel blockers in improving endothelial function has been noted. Our results may be the first to demonstrate the therapeutic benefits in the form of protection against cell membranous ACE2 in HAECs under pressure stress, especially in the presence of Ang II. Recently, additional benefits of nifedipine apart from blood pressure reduction were reported and effects through MMPs were designated as a mechanism of action. 32 Nifedipine has been reported to suppress intracellular signal-transduction cascades, 33 and this may be involved in its action mechanism for ACE2 protection at the HAEC membrane. 23 The present experiments were carried out using a pressurization system that enabled us to simulate the effect of systolic hypertension on cultured endothelial cells derived from large vessels. Therefore, the observations made in these experiments are not likely to apply to other conditions (i.e. diastolic hypertension and endothelial cell response in peripheral arteries). Despite the above limitations, the results of the present study conclusively demonstrate that pulsatile mechanical pressure provoked increased expression of ACE2 mRNA, while supplementation with Ang II depressed this up-regulation in HAECs. The protein expression of ACE2 was not notably affected by the administration of Ang II under pressurized condition, but ACE2 was lost at the cell membrane and upregulated in the cytosol. Moreover, nifedipine suppressed these alterations. Our findings may lead to new thinking on the treatment of hypertension; namely, conservation of cell-surface ACE2 by a calcium channel blocker. 
